Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kelp Products International is a leading agricultural biotechnology company specializing in the production of Kelpak, a high-quality liquid seaweed biostimulant derived from the giant kelp Ecklonia maxima. Founded in 1977 and headquartered in South Africa, the company utilizes a proprietary Cold Cellular Burst extraction process to preserve the delicate natural plant growth regulators, primarily auxins and cytokinins. Kelpak is used globally to enhance root development, improve crop yields, and increase plant resistance to environmental stresses. The company's products are applied across a wide range of agricultural and horticultural sectors, supported by extensive scientific research and field trials. Their commitment to sustainable harvesting and innovative biological solutions has made them a key player in the global biostimulant market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kelpak.